Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia

Diagnostic Microbiology and Infectious Disease

Volumn 55, Issue 3, 2006, Pages 179-184

  Kreisel, Kristen ^a   Boyd, Kristina ^a   Langenberg, Patricia ^a   Roghmann, Mary Claire ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antibiotic therapy duration; Bacteremia; Complication; Recurrence; Staphylococcus aureus infection

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; METICILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG SENSITIVITY; FEMALE; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; RISK FACTOR; RISK REDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; UNITED STATES;

AGED; ANTI-INFECTIVE AGENTS; BACTEREMIA; DRUG ADMINISTRATION SCHEDULE; EPIDEMIOLOGIC METHODS; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; RECURRENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33745261598     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.01.021     Document Type: Article

References (20)

1. Chang F.Y., Peacock Jr. J.E., Musher D.M., et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine 82 (2003) 333-339
2. Davies H.D., McGeer A., Schwartz B., et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N. Engl. J. Med. 335 (1996) 547-554
3. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am. J. Med. 96 (1994) 200-209
4. Ehni W.F., and Reller L.B. Short-course therapy for catheter-associated Staphylococcus aureus bacteremia. Arch. Intern. Med. 149 (1989) 533-536
5. Fowler Jr. V.G., Kong L.K., Corey G.R., et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J. Infect. Dis. 179 (1999) 1157-1161
6. Fowler Jr. V.G., Olsen M.K., Corey G.R., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 163 (2003) 2066-2072
7. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. Am. J. Infect. Control 16 (1988) 128-140
8. Jernigan J.A., and Farr B.M. Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann. Intern. Med. 119 (1993) 304-311
9. Johnson L.B., Almoujahed M.O., Ilg K., Maolood L., and Khatib R. Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse. Scand. J. Infect. Dis. 35 (2003) 782-789
10. Joshi N., Caputo G.M., Weitekamp M.R., and Karchmer A.W. Infections in patients with diabetes mellitus. N. Engl. J. Med. 341 (1999) 1906-1912
11. Kim S.H., Park W.B., Lee K.D., et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin. Infect. Dis. 37 (2003) 794-799
12. Kolpak S., and Mehler P.S. Beware of short-course therapy for Staphylococcus aureus bacteremia without a removable cause. South. Med. J. 93 (2000) 319-320
13. Laupland K.B., Church D.L., Mucenski M., Sutherland L.R., and Davies H.D. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J. Infect. Dis. 187 (2003) 1452-1459
14. Levine D.P., Fromm B.S., and Reddy B.R. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115 (1991) 674-680
15. Lowy F.D. Staphylococcus aureus infections. [see comment]. N. Engl. J. Med. 339 (1998) 520-532
16. National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1992-June 2001, issued August 2001. Am. J. Infect. Control 29 (2001) 404-421
17. Raad I.I., and Sabbagh M.F. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin. Infect. Dis. 14 (1992) 75-82
18. Rosenstein N.E., Perkins B.A., Stephens D.S., et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180 (1999) 1894-1901
19. Whitney C.G., Farley M.M., Hadler J., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343 (2000) 1917-1924
20. Zeylemaker M.M., Jaspers C.A., van Kraaij M.G., Visser M.R., and Hoepelman I.M. Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 380-384